Skip to content
DNDi Logo
  • DNDi INTERNATIONAL
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT DNDi
    • ABOUT DNDi NORTH AMERICA
    • OUR TEAM
    • BOARD OF DIRECTORS
    • OUR PUBLICATIONS
    • FINANCIALS
    • JOBS
    • Close
  • DISEASES & PROJECTS
  • ADVOCACY
  • MEDIA CENTER
  • DONATE
  • CONTACT
    • Close
  • Home

Media Center

RSS SCIENTIFIC ARTICLES

  • Global coalition to accelerate COVID-19 clinical research in resource-limited settings
  • Report of the fifth post-kala-azar dermal leishmaniasis consortium meeting, Colombo, Sri Lanka, 14–16 May 2018
  • WHF IASC roadmap on Chagas disease

RSS PRESS RELEASES

  • Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
  • Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
  • Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease

RSS NEWS

  • How best to prevent and treat COVID-19 in resource-limited settings? We must accelerate research, share knowledge and data, and prioritize access to affordable tools.
  • Message on the passing of Martin Khor from DNDi Executive Director Dr Bernard Pécoul and GARDP Executive Director Dr Manica Balasegaram
  • COVID-19 Pandemic: Statement from DNDi Executive Director Dr Bernard Pécoul

RSS IN THE MEDIA

  • BBC: “Interview Dr Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases, DNDi”
  • The Daily Star: “Accelerating research on the prevention and treatment of COVID-19 in low- and middle-income countries”
  • Hindustan Times: “Global group calls for Covid-19 clinical research in poor nations”

RSS EVENTS

  • MSF Scientific Days International 2020
  • AFRAVIH 2020
  • The International Liver Congress 2020

RSS Scientific Articles

  • Global coalition to accelerate COVID-19 clinical research in resource-limited settings
  • Report of the fifth post-kala-azar dermal leishmaniasis consortium meeting, Colombo, Sri Lanka, 14–16 May 2018
  • WHF IASC roadmap on Chagas disease
  • How clinical research can contribute to strengthening health systems in low resource countries

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Subscribe

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website

Donate

Support research for neglected disease treatments by making a gift

Authorize.net Seal

Charity Status

GuideStar Gold Participantnewyork-ac-seal-vertical-black-web

Social Mission Ratio

DNDi's social mission ratio

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close